サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428353

バイオ医薬品業界における自動化の世界市場レポート 2024

Automation In Biopharma Industry Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオ医薬品業界における自動化の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品業界における自動化の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.6%の年間複合成長率（CAGR）で26億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、データの完全性と文書化の改善、個別化医療の台頭、モジュール式で柔軟なバイオプロセス施設の出現、自動化プラットフォームの進化、バイオシミラーの需要の増大、スマート医療の採用に関連している可能性があります。予測期間中に予想される顕著な動向には、ロボット工学およびオートメーション技術の進歩、シングルユース技術の進歩、バイオプロセシングにおける人工知能の統合、プロセス分析技術（PAT）の開発、バイオ医薬品企業とテクノロジー企業との共同努力、およびバイオ医薬品オートメーションにおける持続可能性を重視などが挙げられます。

バイオ医薬品業界における自動化市場の成長は、医薬品製造におけるロボットの統合の増加によって促進されると予想されます。この文脈において、ロボットとは、医薬品の製造および包装に関連するさまざまな作業に使用される高度な自動化システムおよび機械を指します。これらのロボットは、二次包装、物流施設内、研究室の自動化、ピックアンドプレイス業務、薬局プロセスの自動化、医薬品製造における個別化医療などに応用されています。これらを利用すると、生産性の向上、精度の向上、汚染リスクの軽減、作業者の安全性の向上につながります。たとえば、2021年第3四半期には、北米のロボット市場は大幅な成長を記録し、29,000台、14億8,000万米ドル相当の注文があり、販売台数が37%増加しました。特に、ライフサイエンス、製薬、生物医学分野では、2021年の最初の9か月間でロボット工学の応用が36%もの大幅な急増を経験しました。その結果、医薬品製造におけるロボットの採用の増加により、医薬品製造における自動化の成長が推進されることになります。

バイオ医薬品業界における自動化市場の成長は、医薬品開発のペースの増加によってさらに促進されることが予想されます。医薬品開発のプロセスには、新しい医薬品の発見と市場へのイントロダクションが含まれます。医薬品開発が激化するにつれ、バイオ医薬品業界ではプロセスの自動化が不可欠になっています。自動化システムは、プロセスの合理化、調査の促進、精度の確保、全体的な効率の向上において重要な役割を果たします。たとえば、2022年に医薬品評価研究センター（CDER）は、新規医薬品に分類される37の新薬を承認し、そのうちの54%が同じ年に承認されました。したがって、医薬品開発活動の急増は、バイオ医薬品業界における自動化市場の成長の触媒として機能します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のバイオ医薬品業界における自動化市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 自動化技術
  • デジタル化技術
  • 世界のバイオ医薬品業界における自動化市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 自動化ハードウェア
  • 自動化ソフトウェア
  • サービスプロジェクトフェーズ
  • サービス運用フェーズ
  • 世界のバイオ医薬品業界における自動化市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 臨床フェーズ
  • 創薬フェーズ
  • 生産フェーズ

第7章 地域および国の分析

  • 世界のバイオ医薬品業界における自動化市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のバイオ医薬品業界における自動化市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 市場の競合情勢
  • 市場企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • ABB Ltd
    • Siemens Healthineers AG

第31章 その他の大手および革新的な企業

  • Emerson Electric Co.
  • Becton Dickinson and Company（BD）
  • Corning Incorporated
  • Rockwell Automation Inc.
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Sartorius AG
  • bioMerieux SA
  • Mettler-Toledo International Inc.
  • Beckman Coulter Inc.
  • Waters Corporation
  • Pall Corporation
  • Bruker Corporation
  • Qiagen NV
  • Eppendorf AG

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14198

Automation within the biopharma industry involves the incorporation of advanced technologies and robotics across different stages of the biopharmaceutical manufacturing process. This entails utilizing automated systems and equipment to execute tasks that were conventionally handled by humans, with the aim of enhancing efficiency, precision, and overall productivity in the production of biopharmaceutical products.

The principal technologies driving automation in the biopharma industry encompass automation technology and digitization technology. Automation technology encompasses the utilization of diverse technologies, such as robotics, artificial intelligence (AI), and software systems, to automate and streamline processes and tasks that were traditionally carried out by humans. This includes various components such as automation hardware, automation software, service project phases, and service operation phases, with applications spanning clinical phases, drug discovery phases, and production phases.

The automation in biopharma industry research report is one of a series of new reports from The Business Research Company that provides automation in biopharma industry market statistics, including the automation in biopharma industry's global market size, regional shares, competitors with a automation in biopharma industry market share, detailed automation in biopharma industry market segments, market trends and opportunities, and any further data you may need to thrive in the automation in biopharma industry. This automation in the biopharma industry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The automation in biopharma industry market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historical period can be ascribed to the heightened complexity in biopharmaceutical processes, a necessity for enhanced process efficiency, the expansion of biologics development and manufacturing, a growing demand for quality assurance and control, and the imperative to reduce time-to-market pressures.

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be linked to improvements in data integrity and documentation, the ascent of personalized medicine, the emergence of modular and flexible bioprocessing facilities, the evolution of automation platforms, a growing demand for biosimilars, and the adoption of smart sensors and the Internet of Things (IoT). Prominent trends expected in the forecast period encompass progress in robotics and automation technologies, advancements in single-use technologies, the integration of artificial intelligence in bioprocessing, developments in process analytical technologies (PAT), collaborative efforts between biopharma and technology companies, and an increased emphasis on sustainability in biopharma automation.

The growth of automation in the biopharma industry market is anticipated to be driven by the increasing integration of robots in pharmaceutical manufacturing. In this context, robots refer to sophisticated automated systems and machines employed in various tasks related to the production and packaging of pharmaceutical products. These robots find application in secondary packaging, intralogistics, laboratory automation, pick and place operations, automation of pharmacy processes, and personalized medicine within pharmaceutical manufacturing. Their utilization leads to heightened productivity, improved precision, reduced contamination risks, and enhanced worker safety. For instance, in Q3 2021, the North American robotics market witnessed significant growth, with 29,000 units ordered valued at $1.48 billion, marking a remarkable 37% increase in units sold. Notably, the life sciences, pharmaceutical, and biomedical sectors experienced a substantial 36% surge in the application of robotics during the first nine months of 2021. Consequently, the rising adoption of robots in pharmaceutical manufacturing is poised to propel the growth of automation in the biopharma industry market.

The growth of automation in the biopharma industry market is further expected to be fueled by the increasing pace of drug development. The process of drug development involves the discovery and introduction of new pharmaceutical products to the market. As drug development intensifies, the automation of processes becomes essential within the biopharma industry. Automated systems play a crucial role in streamlining processes, expediting research, ensuring precision, and enhancing overall efficiency. For example, in 2022, the Center for Drug Evaluation and Research (CDER) granted approval to 37 new drugs, categorized as novel drugs, with 54% of them receiving approval in the same year. Hence, the surge in drug development activities acts as a catalyst for the growth of automation in the biopharma industry market.

A prominent trend in the automation in the biopharma industry market is the adoption of technological advancements by major companies. These companies are actively engaged in developing advanced product technologies to fortify their positions in the market. An illustration of this trend is observed in the actions of PerkinElmer Inc., a US-based company providing scientific solutions and technologies. In September 2022, PerkinElmer Inc. introduced the Cellaca PLX Image Cytometry System, an advanced automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. This platform enables researchers to assess critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. The integrated system encompasses image cytometer hardware, software, validated consumables, and trackable data reporting, streamlining calibration and training requirements.

Major companies in the automation in biopharma industry market are actively developing advanced technologies, including automated customer data platforms (CDP)To cater to a larger customer base, boost sales, and increase revenue. An automated CDP is a software solution designed to automatically collect, organize, and analyze customer data from diverse sources in a centralized manner. For instance, Tealium, a US-based provider of customer data orchestration tools, launched Tealium for Pharma in July 2022. This verticalized platform is meticulously crafted to fully automate and enhance the customer experience for Pharma audiences, addressing the challenges posed by dynamic privacy and security regulations in the industry. Tealium's data-first offering integrates and automates data seamlessly, resulting in an elevated customer experience while adhering to the highest standards of Health Insurance Portability and Accountability Act (HIPAA) compliance.

In April 2022, Bruker Corporation, a US-based company specializing in scientific instruments for molecular and materials research, acquired Optimal Industrial Automation Limited for an undisclosed amount. This acquisition positions Bruker as a key provider of software and solutions for small molecule, biologic, and new drug modalities in pharma companies. Optimal Industrial Automation Limited, based in the UK, offers pharmaceutical and biopharmaceutical automation solutions, including process analytical technology (PAT), manufacturing automation, quality assurance (QA) software, and systems integration.

Major companies operating in the automation in biopharma industry market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMerieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

North America was the largest region in the automation in biopharma industry market in 2023. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the automation in biopharma industry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The automation in biopharma industry market consists of revenues earned by entities by providing high-throughput screening, sample management, and cell culture automation used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The automation in biopharma industry market also includes sales of automated dissolution testing systems, robotic sample storage and retrieval systems, and chromatography systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automation In Biopharma Industry Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on automation in biopharma industry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for automation in biopharma industry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The automation in biopharma industry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Automation Technology; Digitization Technology
  • 2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase
  • 3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; ABB Ltd; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Automation In Biopharma Industry Market Characteristics

3. Automation In Biopharma Industry Market Trends And Strategies

4. Automation In Biopharma Industry Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Automation In Biopharma Industry Market Size and Growth

  • 5.1. Global Automation In Biopharma Industry Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Automation In Biopharma Industry Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Automation In Biopharma Industry Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Automation In Biopharma Industry Market Segmentation

  • 6.1. Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automation Technology
  • Digitization Technology
  • 6.2. Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automation Hardware
  • Automation Software
  • Services Project Phase
  • Services Operation Phase
  • 6.3. Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Phase
  • Drug Discovery Phase
  • Production Phase

7. Automation In Biopharma Industry Market Regional And Country Analysis

  • 7.1. Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Automation In Biopharma Industry Market

  • 8.1. Asia-Pacific Automation In Biopharma Industry Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Automation In Biopharma Industry Market

  • 9.1. China Automation In Biopharma Industry Market Overview
  • 9.2. China Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Automation In Biopharma Industry Market

  • 10.1. India Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Automation In Biopharma Industry Market

  • 11.1. Japan Automation In Biopharma Industry Market Overview
  • 11.2. Japan Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Automation In Biopharma Industry Market

  • 12.1. Australia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Automation In Biopharma Industry Market

  • 13.1. Indonesia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Automation In Biopharma Industry Market

  • 14.1. South Korea Automation In Biopharma Industry Market Overview
  • 14.2. South Korea Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Automation In Biopharma Industry Market

  • 15.1. Western Europe Automation In Biopharma Industry Market Overview
  • 15.2. Western Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Automation In Biopharma Industry Market

  • 16.1. UK Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Automation In Biopharma Industry Market

  • 17.1. Germany Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Automation In Biopharma Industry Market

  • 18.1. France Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Automation In Biopharma Industry Market

  • 19.1. Italy Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Automation In Biopharma Industry Market

  • 20.1. Spain Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.12. Spain Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.13. Spain Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Automation In Biopharma Industry Market

  • 21.1. Eastern Europe Automation In Biopharma Industry Market Overview
  • 21.2. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Automation In Biopharma Industry Market

  • 22.1. Russia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Automation In Biopharma Industry Market

  • 23.1. North America Automation In Biopharma Industry Market Overview
  • 23.2. North America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Automation In Biopharma Industry Market

  • 24.1. USA Automation In Biopharma Industry Market Overview
  • 24.2. USA Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Automation In Biopharma Industry Market

  • 25.1. Canada Automation In Biopharma Industry Market Overview
  • 25.2. Canada Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Automation In Biopharma Industry Market

  • 26.1. South America Automation In Biopharma Industry Market Overview
  • 26.2. South America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Automation In Biopharma Industry Market

  • 27.1. Brazil Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Automation In Biopharma Industry Market

  • 28.1. Middle East Automation In Biopharma Industry Market Overview
  • 28.2. Middle East Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Automation In Biopharma Industry Market

  • 29.1. Africa Automation In Biopharma Industry Market Overview
  • 29.2. Africa Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Automation In Biopharma Industry Market Competitive Landscape And Company Profiles

  • 30.1. Automation In Biopharma Industry Market Competitive Landscape
  • 30.2. Automation In Biopharma Industry Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. ABB Ltd
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Automation In Biopharma Industry Market Other Major And Innovative Companies

  • 31.1. Emerson Electric Co.
  • 31.2. Becton Dickinson and Company (BD)
  • 31.3. Corning Incorporated
  • 31.4. Rockwell Automation Inc.
  • 31.5. Agilent Technologies Inc.
  • 31.6. PerkinElmer Inc.
  • 31.7. Sartorius AG
  • 31.8. bioMerieux SA
  • 31.9. Mettler-Toledo International Inc.
  • 31.10. Beckman Coulter Inc.
  • 31.11. Waters Corporation
  • 31.12. Pall Corporation
  • 31.13. Bruker Corporation
  • 31.14. Qiagen N.V.
  • 31.15. Eppendorf AG

32. Global Automation In Biopharma Industry Market Competitive Benchmarking

33. Global Automation In Biopharma Industry Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Automation In Biopharma Industry Market

35. Automation In Biopharma Industry Market Future Outlook and Potential Analysis

  • 35.1 Automation In Biopharma Industry Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Automation In Biopharma Industry Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Automation In Biopharma Industry Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer